TNL Mediagene has a consensus price target of $3.5 based on the ratings of 1 analysts. The high is $3.5 issued by Benchmark on May 20, 2025. The low is $3.5 issued by Benchmark on May 20, 2025. The 1 most-recent analyst ratings were released by Benchmark on May 20, 2025, respectively. With an average price target of $3.5 between Benchmark, there's an implied 540.67% upside for TNL Mediagene from these most-recent analyst ratings.
The latest price target for TNL Mediagene (NASDAQ:TNMG) was reported by Benchmark on May 20, 2025. The analyst firm set a price target for $3.50 expecting TNMG to rise to within 12 months (a possible 540.67% upside). 1 analyst firms have reported ratings in the last year.
The latest analyst rating for TNL Mediagene (NASDAQ:TNMG) was provided by Benchmark, and TNL Mediagene initiated their speculative buy rating.
There is no last upgrade for TNL Mediagene
There is no last downgrade for TNL Mediagene.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of TNL Mediagene, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for TNL Mediagene was filed on May 20, 2025 so you should expect the next rating to be made available sometime around May 20, 2026.
While ratings are subjective and will change, the latest TNL Mediagene (TNMG) rating was a initiated with a price target of $0.00 to $3.50. The current price TNL Mediagene (TNMG) is trading at is $0.55, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.